Anti-Infective Incentives: GAIN, LPAD Won’t Be Enough HHS-Commissioned Report Finds
This article was originally published in RPM Report
Executive Summary
The continuing government interest in incentives for antibacterial development got a boost from an unexpected quarter in June. A report commissioned by HHS calls for a broad package of incentives to stimulate continued investment in new anti-infectives.